Recently, the TEN4CARE consortium gathered in Bilbao for its 6-Month General Assembly. Two intense and highly productive days of co-creation, technical discussion and strategic alignment that are shaping the future of regenerative tendon medicine.
Coordinated by University of Pavia and BioKeralty, TEN4CARE brings together 16 entities from 6 European countries with a shared mission: reducing healing time in tendon injuries and significantly improving patients’ quality of life.
During these two days, partners reviewed the progress achieved in the first six months and aligned the next steps across all work packages. Discussions covered scientific advancements, technological integration, impact pathways and market-oriented strategies. Beyond research progress, the consortium also explored routes for exploitation and commercialization, while reinforcing its commitment to meaningful patient engagement to maximize societal benefit.
One of the highlights of the meeting was the opportunity to see and interact with physical samples of the developed materials. Witnessing tangible results generated great enthusiasm and reinforced the strong momentum of the project.
From Leitat, our colleagues Mario Marotta and Laura Vidal attended the meeting in person. Leitat leads Work Package 5 (Scaffolds preclinical characterization) and has significant participation in Work Package 9 (Integration with minimally invasive surgical techniques towards clinics), contributing key expertise to bring these innovations closer to clinical application.
The progress achieved in just six months confirms that collaboration, multidisciplinary excellence and a shared vision are the driving forces behind transformative healthcare innovation.
